Sign in

CIK 0001438533

  • Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
262383102
Phone
+1 888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,495,607
in 10 filings, $79.5M under 10b5-1 plans

Net −$79,495,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-11-14 ASELAGE STEVE Chief Executive Officer Sale −4,950 $23.63 $117K 259,433
2018-11-14 ASELAGE STEVE Chief Executive Officer Sale −600 $24.58 $15K 258,833
2018-11-09 ROTE WILLIAM E. Senior Vice President, R&D Grant or award +5,000 22,992
2018-11-09 REED ELIZABETH E SVP, GC & Corporate Secretary Grant or award +5,000 22,827
2018-11-09 McFarlane Neil F. Chief Operating Officer Grant or award +10,000 38,476
2018-11-09 Clague Laura Chief Financial Officer Grant or award +7,500 19,533
2018-11-09 ASELAGE STEVE Chief Executive Officer Grant or award +18,500 264,383
2018-08-31 ASELAGE STEVE Chief Executive Officer Option exercise +12,000 $8.70 $104K 257,883
2018-08-31 ASELAGE STEVE Chief Executive Officer Sale −12,000 $32.00 $384K 245,883
2018-08-31 ASELAGE STEVE Chief Executive Officer Option exercise · Employee stock option (right to buy) −12,000 0
2018-07-26 Rosenberg Noah L. Chief Medical Officer Grant or award +10,000 10,000
2018-07-26 Rosenberg Noah L. Chief Medical Officer Grant or award · Employee stock option (right to buy) +65,000 65,000
2018-07-26 Rosenberg Noah L. Chief Medical Officer Grant or award · Performance-based restricted stock units +10,000 10,000
2018-05-10 ROTE WILLIAM E. Senior Vice President, R&D Grant or award +6,500 17,656
2018-05-10 ROTE WILLIAM E. Senior Vice President, R&D Grant or award · Employee stock option (right to buy) +39,000 39,000
2018-05-10 ROTE WILLIAM E. Senior Vice President, R&D Grant or award · Performance-based restricted stock units +6,500 6,500
2018-05-10 REED ELIZABETH E SVP, GC & Corporate Secretary Grant or award +7,000 17,827
2018-05-10 REED ELIZABETH E SVP, GC & Corporate Secretary Grant or award · Employee stock option (right to buy) +42,000 42,000
2018-05-10 REED ELIZABETH E SVP, GC & Corporate Secretary Grant or award · Performance-based restricted stock units +7,000 7,000
2018-05-10 McFarlane Neil F. Chief Operating Officer Grant or award +10,500 27,948

Page 50 of 51 · 1,020 trades